Cargando…
Effect of Fremanezumab Monthly and Quarterly Doses on Efficacy Responses
OBJECTIVE: Exposure‐response (E‐R) models were developed to provide a description of the time‐course of treatment effect for monthly and quarterly dosing regimens of fremanezumab. BACKGROUND: Fremanezumab is a monoclonal antibody for preventive treatment of episodic migraine (EM) and chronic migrain...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496732/ https://www.ncbi.nlm.nih.gov/pubmed/32445498 http://dx.doi.org/10.1111/head.13845 |